Invetech delivers Organovo’s first commercial 3D BioPrinter for manufacturing human tissue and organs
01 December 2009
Invetech delivered the world's first production model 3D bio-printer to Organovo, developers of the proprietary NovoGen bioprinting technology. Organovo will supply the units to research institutions investigating human tissue repair and organ replacement.
Dr. Fred Davis, president of Invetech, said, "Building human organs cell-by-cell was considered science fiction not that long ago. Through this clever combination of technology and science we have helped Organovo develop an instrument that will improve people’s lives, making the regenerative medicine that Organovo provides accessible to people around the world."
Further Press Information
Alan Morris, Phone: +613 9211 7815, Fax: +613 9211 7703. Media Inquiries.